H35.113
Retinopathy of prematurity, stage 0, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Retinopathy of Prematurity (ROP) is a condition that affects premature infants, involving abnormal growth of blood vessels in the retina. When diagnosed at stage 0, the condition is in its earliest form, with no significant changes to the retina. This stage indicates that no active disease process has yet commenced, but close monitoring is vital to prevent potential progression. Stage 0 is characterized by immature retinal development with no observable pathology that impacts vision. Recognizing this stage allows healthcare providers to plan appropriate surveillance and intervention strategies to promote optimal eye health in premature infants.
Causes & Symptoms
Clinical Causes: Premature birth, especially before 31 weeks of gestation Low birth weight, typically less than 1500 grams (3.3 pounds) Presence of oxygen therapy during neonatal care Genetic factors influencing retinal vascular development Environmental factors and overall neonatal health status
Key Symptoms: No noticeable symptoms; often detected during routine eye examinations Potential signs when present could include abnormal eye movements or poor visual responses, but these are not specific at stage 0
Diagnostic & Treatment
Diagnosis Path: Diagnosis of stage 0 ROP involves detailed examination by a pediatric ophthalmologist using specialized tools such as indirect ophthalmoscopy or retinal imaging. The evaluation focuses on assessing the immature retinal vessels and ensuring that no abnormal proliferation or detachment has occurred. Screening is typically performed between 4 to 6 weeks after birth for infants at risk, especially those born prematurely. The ophthalmologist will document the retinal appearance and classify the disease stage, with stage 0 indicating that the retina is immature but with no signs of retinopathy. Regular follow-up examinations are essential to monitor for any progression, especially in high-risk infants.
Treatment Protocols: In the initial stage 0, active treatment is generally not necessary as there are no signs of disease progression. Instead, the primary approach involves careful observation and routine screening to ensure that the condition does not develop into more advanced stages. Should signs of progression appear in later stages—such as abnormal vessel growth, scarring, or retinal detachment—treatment options may include laser therapy, cryotherapy, or intravitreal injections to halt abnormal blood vessel development. Early detection and vigilant follow-up are critical in preventing vision-threatening complications. In addition, managing underlying health issues, maintaining optimal oxygen levels, and ensuring comprehensive neonatal care are essential to minimize the risk of ROP progression.
Clinical Advice & FAQs
Billing Guidance
Is H35.113 a billable ICD-10 code?
Yes, H35.113 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.113?
Clinical documentation must specify the nature of Retinopathy of prematurity, stage 0, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference